• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Synexus opens regional center in Poland to support global clinical trials

Synexus opens regional center in Poland to support global clinical trials

October 30, 2013
CenterWatch Staff

Synexus has opened a regional office for Eastern Europe in Poland, reflecting the company’s commitment to the region.

The new 3,000-square-foot office will house a regional team with over a decade of experience delivering clinical trials for Synexus clients in Eastern Europe. The team will be responsible for patient engagement programs as well as the management of Synexus' nine dedicated research centers across Poland, Hungary, Romania, Ukraine and Bulgaria.

“Our success in the region is based on our ability to deliver patients and quality data to our clients in pharma,” said Dr. Radoslaw Janiak, regional managing director. “We have put in place a sophisticated patient engagement program which really improves the patient experience and it is these added-value extras which really pay dividends in terms of client success."

Christophe Berthoux, CEO of Synexus, said, "We have an exceptional team in Eastern Europe who have consistently met the needs of our customers. For example, it is no accident that the Wroclaw site was the first Synexus site to be selected to join Pfizer's INSPIRE site network."

Sites in INSPIRE, which stands for Investigator Networks, Site Partnerships and Infrastructure for Research Excellence, have early access to Pfizer‘s portfolio data and advanced information regarding clinical trials to be sponsored by Pfizer. They are involved in publication in scientific journals, protocol design, advisory boards and the sharing of best practice across the INSPIRE network.

Synexus, which has more than 25 dedicated research centers across Europe and Africa, focuses on clinical trials in cardiovascular, metabolic (diabetes and obesity), bone, respiratory and CNS (dementia and pain).

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing